DIMension 3™ by Xymogen – Advanced DIM Supplement for Estrogen Metabolism Support
DIMension 3™ by Xymogen is a targeted hormone balance supplement designed to support healthy estrogen metabolism and inflammatory balance. This comprehensive formula combines diindolylmethane (DIM) with bioavailable turmeric and black pepper extracts to promote metabolic detoxification pathways and overall hormonal wellness.
Key DIMension 3™ Benefits
- Supports healthy estrogen metabolism support in both men and women
- Helps maintain balanced hormone activity and cellular health
- Promotes antioxidant and inflammatory response support
- Assists detoxification pathways involved in hormone clearance
- Enhances nutrient absorption with synergistic botanical extracts
How DIMension 3™ Works
DIMension 3™ works by supporting key biochemical pathways involved in hormone metabolism and inflammatory regulation, using clinically studied ingredients with a strong safety profile.
Key Ingredients & Mechanisms:
- Diindolylmethane (DIM) (150 mg): Supports favorable estrogen metabolite ratios and helps promote hormonal balance and cellular protection
- Turmeric Extract (95% curcuminoids) (250 mg): Provides antioxidant support and helps regulate inflammatory pathways associated with hormone metabolism
- Black Pepper Extract (93% piperine) (2.5 mg): Enhances absorption and bioavailability of curcuminoids
- Calcium (62 mg): Supports normal cellular signaling processes
This formulation is well-tolerated and designed for daily use under practitioner guidance.
DIMension 3™ Is Formulated For
- Individuals seeking estrogen metabolism support
- Men and women focused on hormonal balance and detoxification
- Those looking for a clean, professional-grade DIM supplement
- Individuals under practitioner care for hormone-related wellness goals
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Or you may book a FREE product consultation with Holistic Health Partners. You may want to look at our other Hormone Support products.
Recommendation: Xymogen suggests taking two DIMension 3™ capsules daily, or as directed by your healthcare practitioner.
Serving Size: 2 capsules
Servings Per Container: 60 / 120
Turmeric Extract (Curcuma longa) (rhizome) (95% curcuminoids) 250 mg
DIM (diindolylmethane) 150 mg
Black Pepper Extract (Piper nigrum) (fruit) (93% piperine) S1 2.5 mg
Other Ingredients: Capsule (hypromellose and water), magnesium stearate, hydroxypropyl cellulose, silica.
Does Not Contain: Wheat, gluten, corn, yeast, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, sesame, GMOs, artificial colors, or artificial sweeteners.
Cautions: Consult your healthcare practitioner prior to use. Individuals taking medication, especially blood thinners or cancer treatments, should discuss potential interactions. Do not use if tamper seal is damaged.
Storage: Keep closed in a cool, dry place out of reach of children.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited. covenanthealthproducts.com makes XYMOGEN formulas available only to patients of our clinic. If you are a patient of covenanthealthproducts.com, you may inquire about XYMOGEN by calling (800) 627-6518
References:
- Bradlow HL (2008 Jul-Aug) Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer. In Vivo; 22(4):441-5.
- Herrmann S, Seidelin M, Bisgaard HC, et al. (2002 Nov) Indolo[3,2-b]carbazole inhibits gap junctional intercellular communication in rat primary hepatocytes and acts as a potential tumor promoter. Carcinogenesis; 23(11):1861-8.
- Riby JE, Xue L, Chatterji U, et al. (2006 Feb) Activation and potentiation of interferongamma signaling by 3,3'-diindolylmethane in MCF-7 breast cancer cells. Mol Pharmacol; 69(2):430-9.
- Lord RS, Bongiovanni B, Bralley JA. (2002 Apr) Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. Altern Med Rev. 7(2):112-29.